Updated: May 8, 2024
The average Halozyme Therapeutics stock price target is 51.63 with a max estimate of 71.00 and a min estimate of 45.00
Review Halozyme Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: May 8, 2024